Ortataxel
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ECHA InfoCard | 100.158.836 |
Chemical and physical data | |
Formula | C44H57NO17 |
Molar mass | 871.92 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Ortataxel is a drug used in chemotherapy. As of June 2009[update], Spectrum Pharmaceuticals has the drug is in a Phase 2 clinical trial.